Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
10 days of BGP-15 treatment greatly improves diaphragm muscle fiber function (by about 100%)
Erlotinib D6 hydrochloride (CP-358774 D6 hydrochloride) a deuterium labeled Erlotinib Hydrochloride
1 μM) causes accumulation of cells in G2/M in HeLa cells
PB28 dihydrochloride also reduces P-gp expression in a concentration- and time-dependent manner (approximately 60% in MCF7 and 90% in MCF7 ADR)
BTSA1 Size:Contact [email protected] for quotation 10 days of BGP-15 treatmentBTSA1 is a potent, high affinity and orally active BAX activator with an IC50 of 250 nM and an EC50 of 144 nM. BTSA1 binds with high affinity and specificity to the N terminal activation site and induces conformational changes to BAX leading to BAX mediated apoptosis. Product information CAS Number: 314761 14 3 Molecular Weight: 430. 51 Formula: C21H14N6OS2 Chemical Name: 5 phenyl 2 (4 phenyl 1,3 thiazol 2 yl) 4 [2 (1,3 thiazol 2 yl)diazen 1 yl] 2,3
US$ 68.00
US$ 137.70
US$ 805.50
US$ 155.50
US$ 170.99
US$ 275.50
US$ 38.00